{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:28:03Z","timestamp":1720657683337},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Dermatology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.yadr.2006.08.003","type":"journal-article","created":{"date-parts":[[2006,12,23]],"date-time":"2006-12-23T12:14:17Z","timestamp":1166876057000},"page":"1-30","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Skin Signs of Systemic Disease in\u00a0Childhood"],"prefix":"10.1016","volume":"22","author":[{"given":"Amy E.","family":"Gilliam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yadr.2006.08.003_bib1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.11122","article-title":"US incidence of juvenile dermatomyositis, 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry","volume":"49","author":"Mendez","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.yadr.2006.08.003_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00002281-200309000-00013","article-title":"Update on juvenile dermatomyositis: new advances in understanding its etiopathogenesis","volume":"15","author":"Wargula","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib3","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.4049\/jimmunol.172.8.5041","article-title":"Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis?","volume":"172","author":"Reed","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.yadr.2006.08.003_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1067\/mjd.2001.113686","article-title":"Juvenile dermatomyositis: a retrospective review of a 30-year experience","volume":"45","author":"Peloro","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2006.08.003_bib5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/00002281-200311000-00006","article-title":"Skin involvement in dermatomyositis","volume":"15","author":"Santmyire-Rosenberger","year":"2003","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.yadr.2006.08.003_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archderm.139.4.539-a","article-title":"A helpful clinical sign predictive of cancer in adult dermatomyositis: cutaneous necrosis","volume":"139","author":"Mahe","year":"2003","journal-title":"Arch Dermatol"},{"issue":"9250","key":"10.1016\/j.yadr.2006.08.003_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(00)03535-2","article-title":"Relation between dermatomyositis and polymyositis and cancer","volume":"357","author":"Callen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.yadr.2006.08.003_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.122196","article-title":"Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis","volume":"47","author":"Fisler","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1067\/mpd.2001.112473","article-title":"New insight into calcinosis of juvenile dermatomyositis","volume":"138","author":"Mukamel","year":"2001","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.yadr.2006.08.003_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0190-9622(93)70052-U","article-title":"Juvenile dermatomyositis associated with partial lipoatrophy","volume":"28","author":"Kavanagh","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1525-1470.1996.tb00728.x","article-title":"Partial lipodystrophy associated with juvenile dermatomyositis: report of two cases","volume":"13","author":"Quecedo","year":"1996","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib12","first-page":"610","article-title":"Lipodystrophy in patients with juvenile dermatomyositis\u2014evaluation of clinical and metabolic abnormalities","volume":"28","author":"Huemer","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3928\/0090-4481-20050301-11","article-title":"Connective tissue disease in children","volume":"34","author":"Buka","year":"2005","journal-title":"Pediatr Ann"},{"issue":"3","key":"10.1016\/j.yadr.2006.08.003_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","article-title":"Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis","volume":"43","author":"Huber","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.yadr.2006.08.003_bib15","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/art.21378","article-title":"The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids","volume":"52","author":"Ramanan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.yadr.2006.08.003_bib16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1067\/mjd.2002.120620","article-title":"Amyopathic dermatomyositis: retrospective review of 37 cases","volume":"46","author":"El-Azahary","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib17","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/art.21041","article-title":"Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases","volume":"52","author":"Frances","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.yadr.2006.08.003_bib18","first-page":"499","article-title":"Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome","volume":"23","author":"Toubi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.bor.0000137852.42270.0f","article-title":"Update on pediatric systemic lupus erythematosus","volume":"16","author":"Stichweh","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib20","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0031-3955(16)38165-2","article-title":"Collagen vascular diseases of childhood","volume":"38","author":"Jones","year":"1991","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.yadr.2006.08.003_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2133.1998.02373.x","article-title":"Linear cutaneous lupus erythematosus following the lines of Blaschko","volume":"139","author":"Abe","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1525-1470.2003.20201.x","article-title":"Discoid lupus erythematosus in children: clinical, histopathologic, and follow-up features in 27 cases","volume":"20","author":"Moises-Alfaro","year":"2003","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/1529-0131(199901)42:1<69::AID-ANR9>3.0.CO;2-J","article-title":"Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease","volume":"42","author":"Reichlin","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.yadr.2006.08.003_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2165\/00128072-200204040-00004","article-title":"Treatment options for juvenile-onset systemic lupus erythematosus","volume":"4","author":"Carreno","year":"2002","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.yadr.2006.08.003_bib25","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yadr.2006.08.003_bib26","first-page":"2103","article-title":"Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus","volume":"28","author":"Buratti","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib27","first-page":"318","article-title":"Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine","volume":"55","author":"Fu","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.yadr.2006.08.003_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/0961203304lu517rr","article-title":"Vascular and connective tissue diseases in the paediatric world","volume":"13","author":"Falcini","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.yadr.2006.08.003_bib29","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/rheumatology\/39.4.353","article-title":"Systemic lupus erythematosus: a model for atherogenesis?","volume":"39","author":"Manzi","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.yadr.2006.08.003_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.clindermatol.2003.12.019","article-title":"Neonatal lupus erythematosus","volume":"22","author":"Boh","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00002281-200309000-00003","article-title":"Neonatal lupus syndromes","volume":"15","author":"Buyon","year":"2003","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"10.1016\/j.yadr.2006.08.003_bib32","first-page":"832","article-title":"Neonatal lupus erythematosus: report of a case","volume":"88","author":"Luo","year":"1989","journal-title":"Taiwan Yi Xue Hui Za Zhi"},{"key":"10.1016\/j.yadr.2006.08.003_bib33","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/art.10232","article-title":"A serologic marker for fetal risk of congenital heart block","volume":"46","author":"Salomonsson","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.yadr.2006.08.003_bib34","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/archderm.1994.01690100062010","article-title":"The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease","volume":"130","author":"Chu","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2230.2004.01554.x","article-title":"Rheumatoid papules treated with dapsone","volume":"29","author":"Martin","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1525-1470.1994.tb00065.x","article-title":"Pyoderma gangrenosum in infants and children","volume":"11","author":"Graham","year":"1994","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-4632.2004.01806.x","article-title":"Pyoderma Gangrenosum in childhood","volume":"43","author":"Bhat","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib38","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF02002902","article-title":"Familial pyoderma gangrenosum presenting in infancy","volume":"155","author":"Al-Rimawi","year":"1996","journal-title":"Eur J Pediatr"},{"issue":"6","key":"10.1016\/j.yadr.2006.08.003_bib39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1525-1470.2005.00132.x","article-title":"Sweet syndrome in two children","volume":"22","author":"Herron","year":"2005","journal-title":"Pediatr Dermatol"},{"issue":"10","key":"10.1016\/j.yadr.2006.08.003_bib40","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/archderm.1995.01690220081015","article-title":"Sweet's syndrome leading to acquired cutis laxa (Marshall's syndrome) in an infant with alpha 1-antitrypsin deficiency","volume":"131","author":"Hwang","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0190-9622(97)80376-3","article-title":"An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease","volume":"37","author":"Kuniyuki","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.yadr.2006.08.003_bib42","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/adc.2004.071332","article-title":"BCG reactivation: a useful diagnostic tool even for incomplete Kawasaki disease","volume":"90","author":"Sinha","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yadr.2006.08.003_bib43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1067\/mpd.2000.107840","article-title":"Psoriatic eruption in Kawasaki disease","volume":"137","author":"Eberhard","year":"2000","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.yadr.2006.08.003_bib44","first-page":"528","article-title":"Kawasaki's disease with eruptive pustular and guttate psoriasis","volume":"130","author":"Boralevi","year":"2003","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.yadr.2006.08.003_bib45","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/428291","article-title":"Association between a novel human coronavirus and Kawasaki disease","volume":"191","author":"Esper","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.yadr.2006.08.003_bib46","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1086\/497170","article-title":"Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease","volume":"192","author":"Shimizu","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.yadr.2006.08.003_bib47","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1542\/peds.84.4.666","article-title":"Kawasaki disease in families","volume":"84","author":"Fujita","year":"1989","journal-title":"Pediatrics"},{"key":"10.1016\/j.yadr.2006.08.003_bib48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1442-200x.2005.02033.x","article-title":"Kawasaki Disease Research Committee. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)","volume":"47","author":"Ayusawa","year":"2005","journal-title":"Pediatr Int"},{"key":"10.1016\/j.yadr.2006.08.003_bib49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.bor.0000197998.50450.f6","article-title":"Kawasaki disease","volume":"18","author":"Falcini","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib50","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.yadr.2006.08.003_bib51","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","article-title":"Long-term consequences of Kawasaki disease. A 10- to 21- year follow-up study of 594 patients","volume":"94","author":"Kato","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.yadr.2006.08.003_bib52","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/01.bor.0000174184.15901.ee","article-title":"Pathogenesis and treatment of Kawasaki's disease","volume":"17","author":"Yeung","year":"2005","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.yadr.2006.08.003_bib53","first-page":"803","article-title":"Corticosteroid treatment of refractory Kawasaki Disease","volume":"33","author":"Lang","year":"2006","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.yadr.2006.08.003_bib54","first-page":"136","article-title":"Treatment of intravenous immunoglobulin-resistant Kawasaki disease with methotrexate","volume":"34","author":"Ahn","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib55","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpeds.2004.12.022","article-title":"Infliximab treatment for refractory Kawasaki syndrome","volume":"146","author":"Burns","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.yadr.2006.08.003_bib56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.semarthrit.2005.08.007","article-title":"Henoch Schonlein Purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of the literature","volume":"35","author":"Trapani","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.yadr.2006.08.003_bib57","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00431-002-0922-z","article-title":"Risk factors of renal involvement and significant proteinuria in Henoch-Schonlein purpura","volume":"161","author":"Sano","year":"2002","journal-title":"Eur J Pediatr"},{"issue":"4 Pt 1","key":"10.1016\/j.yadr.2006.08.003_bib58","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0190-9622(86)70222-3","article-title":"Henoch-Schonlein vasculitis: direct immunofluorescence study of uninvolved skin","volume":"15","author":"Van Hale","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1741-7015-2-7","article-title":"A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein Purpura","volume":"2","author":"Huber","year":"2004","journal-title":"BMC Med"},{"key":"10.1016\/j.yadr.2006.08.003_bib60","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0091-6749(05)80202-7","article-title":"Acute hemorrhagic edema of infancy (AHEI)\u2014a variant of Henoch-Schonlein purpura or a distinct clinical entity?","volume":"86","author":"Saraclar","year":"1990","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.yadr.2006.08.003_bib61","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0738-081X(01)00232-2","article-title":"Acute hemorrhagic edema of infancy (AHEI)","volume":"20","author":"Smitt","year":"2002","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib62","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1651-2227.1996.tb13904.x","article-title":"Acute haemorrhagic oedema of infancy, a benign variant of leucocytoclastic vasculitis","volume":"85","author":"Krause","year":"1996","journal-title":"Acta Paediatr"},{"issue":"2 Pt 1","key":"10.1016\/j.yadr.2006.08.003_bib63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0190-9622(08)80314-3","article-title":"Seidlmayer's syndrome: postinfectious cockade purpura of early childhood","volume":"26","author":"Cox","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib64","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.20953","article-title":"Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disorder","volume":"52","author":"Lovell","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.yadr.2006.08.003_bib65","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archderm.141.2.248","article-title":"Neonatal-onset multisystem inflammatory disorder: the emerging role of pyrin genes in autoinflammatory disesase","volume":"141","author":"Kilcline","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00002281-200301000-00011","article-title":"The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations","volume":"15","author":"Hull","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib67","doi-asserted-by":"crossref","unstructured":"Zulian F, Athreya BH, Laxer R, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford) 2005 [Epub ahead of print].","DOI":"10.1093\/rheumatology\/kei251"},{"issue":"2","key":"10.1016\/j.yadr.2006.08.003_bib68","first-page":"171","article-title":"Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases","volume":"13","author":"Marzano","year":"2003","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.yadr.2006.08.003_bib69","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmsted County 1960\u20131993","volume":"24","author":"Peterson","year":"1997","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.yadr.2006.08.003_bib70","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society (PRES). Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.yadr.2006.08.003_bib71","first-page":"1997","article-title":"Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre","volume":"30","author":"Blaszczyk","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib72","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0002-9394(79)90567-1","article-title":"Ocular manifestations and treatment of hemifacial atrophy","volume":"88","author":"Muchnick","year":"1979","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.yadr.2006.08.003_bib73","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1046\/j.1365-2133.2003.05289.x","article-title":"Thirteen-megahertz ultrasound probe: its role in diagnosing localized scleroderma","volume":"148","author":"Cosnes","year":"2003","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.yadr.2006.08.003_bib74","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/rheumatology\/41.10.1178","article-title":"Juvenile-onset localized scleroderma activity detection by infrared thermography","volume":"41","author":"Martini","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.yadr.2006.08.003_bib75","doi-asserted-by":"crossref","unstructured":"Cunningham BB, Landells ID, Langman C, et\u00a0al. Topical calcipotriene for morphea\/linear scleroderma. J Am Acad Dermatol 1998;39(2 Pt 1):211\u20135.","DOI":"10.1016\/S0190-9622(98)70077-5"},{"issue":"1","key":"10.1016\/j.yadr.2006.08.003_bib76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(98)70533-X","article-title":"Low-dose UVA phototherapy for treatment of localized scleroderma","volume":"38","author":"Kerscher","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2006.08.003_bib77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1525-1470.2001.018003241.x","article-title":"Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea","volume":"18","author":"Kreuter","year":"2001","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.yadr.2006.08.003_bib78","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-5945-4-11","article-title":"UVA\/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review","volume":"4","author":"Breuckmann","year":"2004","journal-title":"BMC Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2006.08.003_bib79","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2005.11.1063","article-title":"A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma","volume":"54","author":"Kreuter","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.yadr.2006.08.003_bib80","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3476(00)90056-8","article-title":"Methotrexate and corticosteroid therapy for pediatric localized scleroderma","volume":"136","author":"Uziel","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.yadr.2006.08.003_bib81","first-page":"1","article-title":"Morphoea (localized scleroderma): assessment of disease activity and evaluation of treatment using systemic steroids and methotrexate","volume":"153","author":"Harper","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.yadr.2006.08.003_bib82","unstructured":"Meneghesso D, Falcini F, Martini G, et\u00a0al. A prospective clinical and pathological study on the efficacy of combined methotrexate\/corticosteroid treatment in juvenile localized scleroderma. Abstract 1411, American College of Rheumatology meeting. San Diego, California, November 13\u201317, 2005."},{"key":"10.1016\/j.yadr.2006.08.003_bib83","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1524-4725.2003.29307.x","article-title":"Treatment of atrophies secondary to trilinear scleroderma en coup de sabre by autologous tissue cocktail injection","volume":"29","author":"Oh","year":"2003","journal-title":"Dermatol Surg"}],"container-title":["Advances in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882088006000046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882088006000046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T06:29:17Z","timestamp":1683700157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882088006000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":83,"alternative-id":["S0882088006000046"],"URL":"https:\/\/doi.org\/10.1016\/j.yadr.2006.08.003","relation":{},"ISSN":["0882-0880"],"issn-type":[{"value":"0882-0880","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}